Legal & General Group Plc - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 76 filers reported holding CUE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$9,683
-37.0%
4,2100.0%0.00%
Q2 2023$15,366
+156.1%
4,210
+72.3%
0.00%
Q2 2022$6,000
-94.8%
2,443
-89.8%
0.00%
Q1 2022$116,000
-57.0%
23,9460.0%0.00%
Q4 2021$270,000
+28.0%
23,946
+65.1%
0.00%
Q3 2021$211,000
+99.1%
14,507
+59.0%
0.00%
Q2 2021$106,000
-7.8%
9,126
-3.8%
0.00%
Q1 2021$115,000
-0.9%
9,489
+2.0%
0.00%
Q4 2020$116,000
-17.1%
9,2990.0%0.00%
Q3 2020$140,000
-45.3%
9,299
-10.9%
0.00%
Q2 2020$256,000
+481.8%
10,442
+235.0%
0.00%
Q1 2020$44,000
-35.3%
3,117
-26.9%
0.00%
Q4 2019$68,000
+126.7%
4,265
+20.9%
0.00%
Q3 2019$30,000
+50.0%
3,527
+34.2%
0.00%
Q2 2019$20,0000.0%2,6280.0%0.00%
Q1 2019$20,000
+66.7%
2,6280.0%0.00%
Q4 2018$12,000
-50.0%
2,6280.0%0.00%
Q3 2018$24,000
-22.6%
2,6280.0%0.00%
Q2 2018$31,000
+40.9%
2,628
+68.6%
0.00%
Q1 2018$22,0001,5590.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,840,510$5,245,4542.86%
P.A.W. CAPITAL CORP 180,000$513,0001.40%
Bleichroeder LP 861,278$2,454,6420.53%
Monaco Asset Management SAM 497,177$1,416,9540.43%
Slate Path Capital LP 2,402,455$6,846,9970.37%
SILVERARC CAPITAL MANAGEMENT, LLC 306,278$872,8920.25%
Robertson Stephens Wealth Management, LLC 478,500$1,363,7250.13%
CARLSON CAPITAL L P 365,000$1,040,2500.08%
Voss Capital, LLC 125,000$356,2500.07%
ADVISORY RESEARCH INC 257,225$733,0910.07%
View complete list of CUE BIOPHARMA INC shareholders